Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

The Procter & Gamble Company (PG) Earnings: The Good, the Bad, and the Ugly

The Procter & Gamble Company (NYSE:PG) reported earnings for its fiscal third quarter yesterday, and there was a lot to like in the company’s results. But P&G also delivered some bad news to investors. And there were a few tidbits in the report that were downright ugly.

Here’s how things shook out for the company’s latest results.

The good
The best news for P&G shareholders came in the form of strong profits. Earnings were up 7%, as P&G’s cost-cutting program continued to pay dividends. Better yet, the company’s sales growth came mostly from volume increases rather than price boosts, flipping the trend from past quarters. And P&G also managed to claw back more of the market share it had lost, with gains in over two-thirds of its business in the U.S., and over 50%, companywide.

The bad
Unfortunately, those sales gains were below the market’s expectations, and at the low end of The Procter & Gamble Company (NYSE:PG)’s own guidance. The company reported just 3% revenue growth for the quarter, meaning that it won’t have the blockbuster end to its fiscal year that it had hoped for.

The Procter & Gamble Company (NYSE:PG)By comparison, rival Unilever N.V. (ADR) (NYSE:UN) managed to grow sales by 5% last quarter on a better than 8% rise in its personal care business. P&G had been aiming for its new product pipeline to drive bigger revenue gains, but that hasn’t happened.

The ugly
The Procter & Gamble Company (NYSE:PG)’s worst-performing business was its beauty segment. Sales fell by 1%, as rivals turned up their level of promotions and succeeded in fending off P&G’s competitive attacks. The Olay skin care line continued its struggles, and new hair care product introductions from Vidal Sassoon and Pantene just weren’t strong enough to spark sales growth.

DOWNLOAD FREE REPORT: Warren Buffett's Best Stock Picks

Let Warren Buffett, George Soros, Steve Cohen, and Daniel Loeb WORK FOR YOU.

If you want to beat the low cost index funds by 19 percentage points per year, look no further than our monthly newsletter.In this free report you can find an in-depth analysis of the performance of Warren Buffett's entire historical stock picks. We uncovered Warren Buffett's Best Stock Picks and a way to for Buffett to improve his returns by more than 4 percentage points per year.

Bonus Biotech Stock Pick: You can also find a detailed bonus biotech stock pick that we expect to return more than 50% within 12 months.
Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.